Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

INVA vs EAF: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

INVA Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 7–3 Matrix Metrics)

INVA Overall Winner 6-Pillar Tally: INVA 5 – 1 EAF Matrix Metrics: INVA 7 – 3 EAF

As of Nov 19, 2026, Innoviva, Inc. (INVA) is the stronger overall head-to-head candidate over GrafTech International Ltd. (EAF) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). INVA carries a Unified Composite Score of 59.9/100 (HOLD) at $18.41 (8.9x Forward P/E, 39.5% operating margin), whereas EAF carries 39.6/100 (SELL) at $7.92 (6.8x Forward P/E, -17.3% operating margin).

  • Technical & Structure Timing Caution: INVA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 29.5); meanwhile EAF is in a Breakdown options structure phase (RSI 39.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About INVA vs EAF
INVA NASDAQ Head-to-Head Winner
Innoviva, Inc. Common Stock
Pharmaceutical Preparations
$18.41
+0.05% 1D
Market Cap $1.3B
TTM Revenue $438M
Forward P/E 8.9x
Beta / 30D Vol 0.31β · 36% Vol
Unified Composite Score
59.9 / 100 HOLD
Tech 72.0 Fund 68.0 Flow 64.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -2.4%), weak momentum, RSI 30
RSI-14: 29.5 · SMA20: $19.82 · SMA50: $20.48
EAF NYSE
GrafTech International Ltd.
Electrical Industrial Apparatus
$7.92
-3.77% 1D
Market Cap $221.4M
TTM Revenue $509M
Forward P/E 6.8x
Beta / 30D Vol 2.53β · 143% Vol
Unified Composite Score
39.6 / 100 SELL
Tech 15.0 Fund 41.0 Flow 57.0 Mom 70.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 40
RSI-14: 39.7 · SMA20: $10.30 · SMA50: $9.25

6-Pillar Scorecard Institutional Category Breakdown (INVA 5 – 1 EAF)

Columns: Metric · INVA · EAF
1. Valuation Multiples EAF
Forward P/E 8.9x 6.8x
Trailing P/E 7.8x 6.8x
PEG Ratio 2.74x N/M
EV / Revenue 2.3x 2.5x
2. Growth & Scale INVA
Revenue Growth (YoY) -1.6% -2.7%
Earnings Growth (YoY) +590.4% -63.5%
TTM Revenue (USD) $438M $509M
Market Cap $1.3B $221.4M
3. Profitability & Quality INVA
Gross Margin 77.0% -6.4%
Operating Margin 39.5% -17.3%
Net Profit Margin 44.1% -38.4%
Return on Equity (ROE) 18.0% -213.7%
4. Balance Sheet & Cash Flow INVA
Cash Generation (TTM) $183M -$158M
Cash Flow Margin 41.6% -31.1%
Net Cash / Leverage $312M Net Cash $1.07B Net Debt
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning INVA
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile 35.8% (7th %ile) 102.9% (15th %ile)
Put/Call OI Skew N/A 0.70x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markdown DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat INVA
OpEx & R&D Intensity 37.5% of Rev ($164M) 10.9% of Rev ($55M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Electrical Equipment & Parts Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: INVA (7) vs EAF (3)
Institutional Metric INVA EAF Criterion Row Edge
Market Capitalization
Scale
$1.3B $221.4M Larger Scale INVA
Trailing P/E Ratio
Valuation
7.8x 6.8x Lower Multiple EAF
Forward P/E Ratio
Valuation
8.9x 6.8x Lower Multiple EAF
Revenue Growth (YoY)
Growth
-1.6% -2.7% Higher Growth INVA
Operating Margin (TTM)
Profitability
39.5% -17.3% Higher Margin INVA
Net Profit Margin
Profitability
44.1% -38.4% Higher Margin INVA
Return on Equity (ROE)
Capital Efficiency
18.0% -213.7% Higher ROE INVA
52-Week Range Position
Momentum
3% ($18–$25) 20% ($5–$20) Stronger Trend EAF
Beta / 30D Volatility
Risk Regime
0.31β · 36% Vol 2.53β · 143% Vol Lower Realized Risk INVA
Unified Institutional Score
Composite Signal
59.9 / 100 (HOLD) 39.6 / 100 (SELL) Higher Composite INVA
Trailing 12M Revenue (USD)
Operating Scale
$438M $509M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
77.0% -6.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
2.74x PEG · 2.3x EV/Rev N/M PEG · 2.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$183M ($312M Net Cash) -$158M ($1.07B Net Debt) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon EAF +18.27 pp
INVA: -11.96% · EAF: +6.31%
3M Horizon EAF +28.58 pp
INVA: -12.62% · EAF: +15.96%
6M Horizon EAF +9.06 pp
INVA: -17.07% · EAF: -8.01%
1Y Horizon INVA +22.78 pp
INVA: -15.82% · EAF: -38.6%

Financial Trajectory Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant USD Revenue & Operating Margin (%)
Period INVA Revenue EAF Revenue INVA Op. Margin EAF Op. Margin Margin Leader
Q3 '25 $430M $580M 32.1% -3.6% INVA
Q4 '25 $460M $470M 34.0% -33.6% INVA
Q1 '26 $390M $500M 38.9% -24.5% INVA
Q2 '26 $480M $510M 42.5% -11.4% INVA
Q3 '26 $420M $560M 39.7% -6.3% INVA

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
INVA UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 35.8%
IV Percentile 7th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact INVA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
EAF BREAKDOWN
119d in phase · OBV DISTRIBUTION
Current IV 102.9%
IV Percentile 15th %ile
Put/Call OI Skew 0.70x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact EAF Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
INVA Moat Profile High-Margin Pricing Power Moat
Biotechnology Operator
Competes within the Biotechnology value chain with $1.3B market capitalization and 39.5% operating margin.
OpEx & R&D Reinvestment 37.5% of Rev ($164M)
90D Engineering Disclosures 0 Published
EAF Moat Profile Cyclical / Execution-Driven Positioning
Electrical Equipment & Parts Operator
Competes within the Electrical Equipment & Parts value chain with $221.4M market capitalization and -17.3% operating margin.
OpEx & R&D Reinvestment 10.9% of Rev ($55M)
90D Engineering Disclosures 0 Published

Investor FAQ INVA vs EAF Key Questions & Quantitative Answers

As of Nov 19, 2026, Innoviva, Inc. (INVA) is the stronger overall head-to-head candidate over GrafTech International Ltd. (EAF) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). INVA carries a Unified Composite Score of 59.9/100 (HOLD) at $18.41 (8.9x Forward P/E, 39.5% operating margin), whereas EAF carries 39.6/100 (SELL) at $7.92 (6.8x Forward P/E, -17.3% operating margin). Technical & Structure Timing Caution: INVA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 29.5); meanwhile EAF is in a Breakdown options structure phase (RSI 39.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

INVA leads the Growth & Scale pillar: INVA posts -1.6% YoY revenue growth and +590.4% YoY earnings growth on $438M TTM revenue (77.0% gross margin, 39.5% operating margin), compared with EAF at -2.7% YoY revenue growth and -63.5% YoY earnings growth on $509M TTM revenue (-6.4% gross margin, -17.3% operating margin). Across the 5-period historical trajectory (Q3 '25 to Q3 '26), INVA cumulative revenue shifted -2.3% while EAF shifted -3.4%. In operating R&D and SG&A reinvestment, INVA deploys 37.5% of Rev ($164M) (0 90-day corporate R&D disclosures) versus 10.9% of Rev ($55M) (0 disclosures) for EAF.

EAF screens cheaper on headline valuation multiples. INVA trades at 8.9x Forward P/E, 7.8x Trailing P/E, 2.74x PEG, and 2.3x EV/Revenue (41.6% FCF margin), whereas EAF trades at 6.8x Forward P/E, 6.8x Trailing P/E, N/M PEG, and 2.5x EV/Revenue (-31.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against INVA (18.0% ROE) versus EAF (-213.7% ROE) capital efficiency.

In options market volatility and institutional positioning, INVA carries 35.8% implied volatility (7th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.31β · 36% Vol realized risk). By comparison, EAF carries 102.9% implied volatility (15th %ile, Compressed (<25th %ile)), a 0.70x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (2.53β · 143% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.